Department of Radiology, Michigan Medicine.
Clin Nucl Med. 2019 Jul;44(7):594-595. doi: 10.1097/RLU.0000000000002629.
A 78-year-old man with biochemically recurrent prostate adenocarcinoma (prostate-specific antigen, 2.3 ng/mL) but without detectable disease in the chest, abdomen, or pelvis at conventional CT imaging or in the bones at Tc-MDP scintigraphy underwent F-fluciclovine (anti-1-amino-3-F-fluorocyclobutane-1-carboxylic acid) PET/CT to evaluate for occult recurrent or metastatic disease. Imaging identified intense radiotracer uptake within 3 dural-based lesions along the left cerebral convexity. Subsequent MRI and biopsy confirmed multifocal World Health Organization grade 2 atypical meningiomas. Focal intracranial radiotracer uptake at F-fluciclovine PET/CT may create a diagnostic dilemma as incidental meningiomas can mimic intracranial metastases.
一位 78 岁男性,患有生化复发性前列腺腺癌(前列腺特异性抗原,2.3ng/mL),但在常规 CT 成像或 Tc-MDP 闪烁扫描中未检测到胸部、腹部或骨盆疾病,也未在骨骼中检测到疾病。他进行了 F-氟代赖氨酸(抗-1-氨基-3-F-氟环丁烷-1-羧酸)PET/CT 检查,以评估隐匿性复发性或转移性疾病。成像显示左大脑凸面有 3 个硬脑膜基底部病变,放射性示踪剂摄取明显。随后的 MRI 和活检证实为多发性世界卫生组织 2 级非典型脑膜瘤。F-氟代赖氨酸 PET/CT 中的局灶性颅内放射性示踪剂摄取可能会造成诊断上的困境,因为偶然发现的脑膜瘤可能类似于颅内转移。